- Wall Street in mixed mood at the start of Monday's session
- Early data show weaker iPhone 16 sales
- Intel gains after communication about cooperation with Pentagon
- Morgan Stanley cuts target price for Micron shares
US markets open Monday's cash session in mixed mood. Five minutes after Wall Street opened, the Nasdaq is losing 0.5%, while the S&P500 is down 0.1%. The Russell 200 is doing relatively well, adding 0.45%. Investor attention today is focused on corporate news.
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile appCurrent volatility observed on Wall Street. Source: xStation
US100
The Nasdaq-100 index, represented by the US100 is trading 0.51% lower today compared to the close of Friday's trading. It is worth noting, however, that last week's gains knocked the index above the resistance zone, which was the 50-day exponential moving average (blue curve on the chart). It is the maintenance of this zone in the medium term that could be an important element defining the US100's sustained return to the uptrend. In the medium term, on the other hand, an important point of support may be the psychological zone near the 100-day and 200-day EMAs (purple curve and gold curve). The zone repeatedly tested by the demand and supply side near 19740 points can now be considered key resistance.
Source: xStation 5
Corporate news
Apple (AAPL.US) shares are down 2.4% early in Monday's session, as demand for the iPhone 16 Pro is lower than expected, based on an analysis of pre-orders for the first weekend.
Sales of the iPhone 16 series pre-orders in the first weekend are estimated at about 37 million units, down about 12.7% year-on-year compared to the iPhone 15 launch.
Intel (INTC.US) is up nearly 2%, after the chipmaker officially qualified for as much as $3.5 billion in federal grants to produce semiconductors for the Pentagon.
Trump Media (DJT.US) is up 1.9%, after Donald Trump said he has “absolutely no intention of selling” his shares when the “lockup” expires later this week.
Volatility is high today on Micron (MU.US), which is losing 2.8% after Morgan Stanley cut its target price on the company's shares by $40 from its last valuation, to $100 per share.
ANALYSTS' RECOMMENDATION
- Summit Therapeutics (SMMT.US): HC Wainwright raised the target price on the company's shares to $45 per share versus $30 previously.
- Carvana (CVNA.US): Evercore raised its target price for the company's shares to $157 per share versus $142 previously.
The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.
